Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review

Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review

Objectives To examine the evidence derived from randomized controlled clinical trials on the efficacy and safety of omalizumab compared to placebo in controlling symptoms of chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU).Data source The electronic databases PubMed, Medline, EMB...

Full description

Bibliographic Details
Main Authors: Diana C. Carrillo, Mario Sanchez Borges, Elizabeth García, Eduardo Egea, Carlos D. Serrano
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455119302376

Internet

http://www.sciencedirect.com/science/article/pii/S1939455119302376

Similar Items